Enterprise 2 Vascular Reconstruction Device
NCT: NCT05254067 · COMPLETED
NCT IDNCT05254067
StatusCOMPLETED
Start Date2017-02-28
Completion2026-01-05
Brief Summary
The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.
Frequently Asked Questions
What is Enterprise 2 Vascular Reconstruction Device?
Enterprise 2 Vascular Reconstruction Device is a clinical trial registered under NCT05254067. Current status: COMPLETED.
What is the status of NCT05254067?
The current status of NCT05254067 (Enterprise 2 Vascular Reconstruction Device) is: COMPLETED.
When did Enterprise 2 Vascular Reconstruction Device start?
Enterprise 2 Vascular Reconstruction Device started on 2017-02-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.